期刊文献+

超声与MRI鉴别不确定性盆腔肿块性质的价值

下载PDF
导出
摘要 目的:探讨超声与MRI鉴别不确定性盆腔肿块性质的价值。方法:以68例不确定性盆腔肿块患者为对象,接受超声及MRI检查,比较两种方式单独及结合病史(和)或肿瘤标志物诊断的价值。结果:68例不确定性盆腔肿块患者中5例(7.35%)怀疑为输卵管炎症,经随访确诊,其余63例(92.65%)患者接受手术切除,经手术病理检查确定良性病灶35例(55.56%),恶性病灶27例(44.44%)。单独MRI检查鉴别不确定性盆腔肿块性质的准确度为82.35%,高于超声造影(66.18%,P<0.05)。超声结合病史和(或)肿瘤标志物后诊断不确定性盆腔肿块性质的准确度比较无差异(P>0.05)。结论:结合病史及肿瘤标志物可提高不确定性盆腔肿块性质的诊断价值,超声结合患者的疾病史与肿瘤标志物可获得与MRI扫描相近的结果。
出处 《现代医用影像学》 2024年第1期82-85,共4页 Modern Medical Imageology
  • 相关文献

参考文献7

二级参考文献65

  • 1楼海亚,孟华,朱庆莉,张青,姜玉新.四种恶性风险指数在附件肿块良恶性诊断中的应用价值[J].中国医学科学院学报,2010,32(3):297-302. 被引量:10
  • 2冉海涛,任红,王志刚,郑元义,张群霞,李小东,许川山.一种新型高分子聚合材料微泡超声造影剂的制备与体外显影实验[J].中华超声影像学杂志,2005,14(10):774-776. 被引量:26
  • 3Young R, Walton L, Ellenberg S, et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer, result of two pro- spective randomized trial[ J ]. N Engl J Med, 1990, 322: 1021- 1024.
  • 4Jacobs I, Oram I), Fairbanks J, et al. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer [ J ]. Br J Ob- stet Gynaecol, 1990,97 (10) :922-929.
  • 5Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses [ J ]. Br J Obstet Gynaecol, 1996,103 ( 8 ) :826-831.
  • 6Roman LD. Small cystic pelvic masses in older women: is surgi- cal removal necessary? [ J]. Gynecol Oncol, 1998,69 : 1-2.
  • 7ModesittSC, Pavlik EJ, Ueland FR, et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 cm in diameter: a long-term follow-up study[J]. Obstet Gynecol,2003,102:594- 599.
  • 8McDonald JM, Doran S, DeSimone CP, et al. Predicting risk of malignancy in adnexal masses [ J ]. Obstet Gynecol, 2010,115 : 687-694.
  • 9Karam AK,Karlan BY. Ovarian cancer: the duplicity of CA125 measurement [ J ]. Nat Rev Clin Oneol, 2010,7 (6) :335-339.
  • 10Han L Y,Karavasilis V, Hagen T, et al. Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy [ J ]. Eur J Cancer,2010,46 ( 8 ) : 1359-1364.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部